Jump to content

RxTrials Institute Drug Pipeline Alert (Pituitary)


Recommended Posts

  • Chief Cushie



RxTrials Institute Drug Pipeline Alert

Jan. 16, 2008 | Vol. 6 No. 3


Ipsen, The Salk Institute Sign Strategic Research Agreement


French drugmaker Ipsen and California's The Salk Institute for Biological Studies will sign a memorandum of understanding setting the framework for the creation of the Ipsen Life Sciences Program at The Salk Institute.


Ipsen will provide funding for research programs in the field of proliferative diseases with a particular emphasis on novel therapeutic concepts for the treatment of pituitary adenomas, the company said.

Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

  • Create New...